The use of vitamin E supplements in the prevention and treatment of Alzheimer’s disease has been studied for a long time and still controversial: The scientific [...]
Can the course of early Alzheimer's disease be delayed by consuming a special mixture of nutrients? This question was investigated in the European study called 'LipiDiDiet' led by Prof. Tobias Hartmann. The scientists recruited Alzheimer's patients, who were in the early stages of the disease, to test the effectiveness of a specific nutritional drink called 'Souvenaid'. Souvenaid was developed as a medical dietary food for the treatment of early-stage Alzheimer's disease and is marketed by Nutricia (Danone Group). It contains a defined nutrient combination of long-chain omega-3 fatty acids, phospholipids, choline, B vitamins (B6, B12 and folic acid), vitamins C and E, selenium and uridine monophosphate.
This descriptive documentation of the Arte TV channel shows very clearly the connections between an unbalanced diet, the resulting micronutrient deficiencies and the effects on the brain. Various experiments have shown that mice that grow up with a deficiency of omega-3 fatty acids have deficits in the formation of their neurons and are much more anxious.
© Copyright by Deutsche Stiftung für Gesundheitsinformation und Prävention | All Rights Reserved
